The next wearable tech could be a face 'tattoo' that measures mental stress
Researchers are developing a digital "tattoo" that measures "mental workload."
The "e-tattoo" is meant for workers with high-risk jobs like air traffic controllers.
It's thinner and lighter than older EEG models.
Tattoos can reveal a lot about a person.
One day, they could even reveal a person's brain waves.
At least, that's the goal for researchers at the University of Texas at Austin.
"This tattoo is not like a normal tattoo," Nanshu Lu, a professor in the university's Department of Aerospace Engineering and Engineering Mechanics, told Business Insider.
Lu worked alongside engineering professor Luis Sentis and others to develop an ultra-thin, wireless wearable device that she compared to a temporary tattoo sticker. The non-invasive device, applied to the skin with an adhesive, measures brain activity and eye movement to gauge an individual's mental workload.
Lu said the device is intended for people working in high-stakes or high-demand jobs, such as aircraft pilots, air traffic controllers, drone operators, and robot teleoperators. These jobs could be considered high-stress since they require focus, quick-thinking skills, and a small margin for error.
"Technology is developing much faster than human evolution, so it is very hard to keep up with the technological demand in modern jobs," she said. "Therefore, it's very important not to overload the operator because not only would that jeopardize the outcome of the mission, it would also harm their health."
Although the idea of an electronic tattoo might sound like something out of a sci-fi novel, humans and technology have been melding for a while.
Nearly 40 years ago, for example, the first fully digital hearing aid became available to the public, according to the Hearing Health Foundation. And now, Elon Musk is embedding computer chips into people's brains through his company, Neuralink.
Recent wearable tech inventions include smartwatches, Bluetooth headphones, VR headsets, and fitness trackers, to name a few. Some health-conscious folks invest in wearable technology like the Oura Ring, which collects data on everything from sleep activity to body temperature.
However, those devices don't analyze brain activity and eye movement.
"Over the years, we developed a series of non-invasive skin conformable e-tattoos to measure cardiovascular health, then measure the mental stress from the palm sweating," Lu said of previous devices she helped develop. "Now, finally, we move on to the brainwave."
Lu said the device certainly isn't the first or only EEG sensor on the market, but it's smaller and lighter than previous models. Conducting an EEG test typically requires attaching electrodes to an individual's full scalp with a gel or paste to collect data, which can be time-consuming.
Researchers at the University of Texas at Austin are attempting to streamline that process by proving mental workload can be measured only from the forehead. During lab tests, participants did memorization drills that involved a screen with flashing boxes.
"In the past, there was no way to objectively assess mental workload. The subjects have to finish the test and then a questionnaire," Lu said. "But in the future, if we can implement some lightweight machine learning model directly on a microprocessor in the Bluetooth chip on e-tattoo, then yes, our goal is to one day be able to do it in real time."
A report by Grand View Research said that the global wearable technology market was worth $84.2 billion in 2024 and is expected to reach $186.14 billion by 2030, underscoring consumers' willingness to integrate technology into their everyday lives.
However, electronic tattoos won't be commercial anytime soon. Lu and her fellow researchers are still conducting tests on and developing the tech.
Still, she can imagine a world where the e-tattoo is used by people not employed in high-stakes jobs.
It could be used by "people who would like to focus as well as people who want to meditate to see if they are truly relaxed," Lu said.
Read the original article on Business Insider
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
39 minutes ago
- Medscape
Fast Five Quiz: How Much Do You Know About Bell Palsy?
Bell palsy, or idiopathic facial paralysis, is the most common peripheral paralysis of the facial nerve (cranial nerve VII). Many cases of facial nerve paralysis have identifiable etiologies, such as stroke, Lyme disease, or Ramsay Hunt syndrome, but Bell palsy is, by definition, idiopathic in nature. How much do you know about Bell palsy and its management? Check your knowledge with this quick quiz. Type 2 diabetes is associated with several types of peripheral neuropathy, including Bell palsy. The prevalence of peripheral neuropathy among patients with type 2 diabetes has been calculated to be as high as 53.6%. In one retrospective cohort study, 33% of participants with Bell palsy had coexisting type 2 diabetes. Additionally, obesity might increase the risk for Bell palsy. Some studies have concluded that there is a slight female preponderance among patients with Bell palsy, whereas others have found no sex predilection. Even if female sex is not a risk factor, evidence suggests that Bell palsy is associated with pregnancy. The median age of onset is 40 years, and patient age < 15 years is not a risk factor. However, Bell palsy has been identified in children and even infants. Facial nerve trauma can certainly cause symptoms resembling Bell palsy, but Bell palsy is idiopathic and does not have a traumatic etiology. If these symptoms resulted from trauma, the diagnosis would be traumatic facial nerve palsy rather than Bell palsy. Learn more about Bell palsy epidemiology. Lagophthalmos, but not true eyelid ptosis, is a characteristic feature of Bell palsy. Symptoms of Bell palsy typically have a rapid onset, manifesting from 24 to 72 hours and often resolving or partially resolving within a few weeks to 3 months. In Bell palsy, facial paralysis is usually unilateral, and bilateral facial paralysis should lead to consideration and evaluation for other etiologies. Hearing loss is not a typical symptom of Bell palsy. The presence of hearing loss indicates an association with an upper motor neuron lesion or a lesion involving more than the facial nerve. Learn more about Bell palsy presentation. A rapid evidence review on Bell palsy points out that, as the condition is idiopathic, laboratory diagnostics are not required for a diagnosis. Clinical practice guidelines from the American Academy of Otolaryngology-Head and Neck Surgery concur that diagnostic testing is not needed to identify Bell palsy. The guidelines recommend that clinicians should not obtain routine laboratory testing in patients with new-onset Bell palsy, pointing out that this approach is not cost-effective. However, both the rapid evidence review and guidelines state that laboratory testing can help identify systemic causes of facial palsy symptoms, such as Lyme disease or diabetes, when reasonable clinical suspicion exists. Learn more about workup for Bell palsy. Oral corticosteroids are recommended in a rapid evidence review as the first-line treatment for Bell palsy. Guidelines from the American Academy of Otolaryngology-Head and Neck Surgery also recommend this approach in patients age = 16 years with Bell palsy. Antiviral monotherapy has not been demonstrated to influence recovery and should be avoided. However, combination therapy with oral corticosteroids and antivirals should be considered, as this approach consistently results in lower rates of synkinesis and might reduce rates of incomplete recovery. Local injectable anesthetic would not be an appropriate therapy because it would not address the underlying cause, lower motor neuron palsy. There is no evidence-based role for local anesthetic in the treatment of Bell palsy. Electroconvulsive therapy is mostly used in the treatment of severe mood disorders. The mechanism of action would not be expected to be useful in the treatment of facial nerve palsy. Learn more about management of Bell palsy. Along with the Sunnybrook facial grading system, the House-Brackmann scale is widely used to qualify symptom severity of Bell palsy. A patient with obvious facial weakness, inability to move the forehead, incomplete closure of the eyelids, and mouth asymmetry with maximal effort would be grade IV, moderately severe symptoms. Grade I is classified as a normal presentation with full facial function in all areas. Grade II is characterized by slight facial weakness on close inspection, slight synkinesis, and no lagophthalmos. Grade III would exhibit moderate symptoms with noticeable, but not severe, synkinesis; obvious facial asymmetry but not disfiguring; complete eyelid closure with effort; and slightly weak mouth even with maximal effort. Learn more about Bell palsy prognosis.
CBS News
an hour ago
- CBS News
Thousands of kids take part in T.D. Jakes Foundation STEAM Expo
Thousands of children and families gathered Saturday at the Shops at RedBird for the T.D. Jakes Foundation's second annual STEAM Expo, a hands-on event designed to spark curiosity and creativity in science, technology, engineering, arts and math. Hands-on learning inspires young minds Excited lines of kids and parents streamed into the venue, where they explored interactive booths, live demonstrations and family-friendly activities. Topics ranged from human anatomy and artificial intelligence to sports medicine and forestry. Five-year-old Leondri Stiggle was especially enthusiastic about the science experiments. "It feels hot, so hot! We made lotion, and it feels like it's juice," she said. Her father, Leon Stiggle, said he wished he had access to similar opportunities as a child. "When you start early, it always evolves into something better," he said. "It's good they have this program — shout out to T.D. Jakes. Appreciate it!" Juneteenth education adds cultural depth The event also featured educational exhibits on Juneteenth, including live actors portraying historical figures such as Fort Worth's Dr. Opal Lee, known as the "grandmother of Juneteenth." The Southwest Dallas County Alumnae Chapter of Delta Sigma Theta Sorority Inc. sponsored the exhibit. "We also have other living exhibits where you can learn about the Emancipation Proclamation and educational development," said chapter president Maiya Bangurah. Building a future-ready workforce Kelley Cornish, president of the T.D. Jakes Foundation, said the expo marked the nonprofit's 10th pop-up event in two years. "People don't realize what an incredible field this is," Cornish said. "We've learned that 2.4 million jobs go unfilled every year because there's no pipeline. We're starting early. Exposure to these careers can literally change a family's dynamic." The foundation's next event is scheduled for the fall.
Yahoo
an hour ago
- Yahoo
Check Your Freezer—FDA Announces Potentially Life-Threatening Recall of Popular Ice Cream
Summer is just around the corner and ice cream is the quintessential warm weather treat. But if you have a carton or two chilling in your freezer, you might want to check the label. Breyers recently issued a recall on 6,668 cases of ice cream due to "undeclared allergens and mislabeled product." According to the FDA, the voluntary recall was initiated on June 2 because Breyers Rocky Road, which contains the almonds, was packaged incorrectly. The ice cream was packaged in Breyers Chocolate Truffle tubs with Rocky Road lids, which may be a concern for anyone who purchased the product and has a nut allergy. While almonds are a tree nut, the Chocolate Truffle tubs offer misleading ingredient information. The tubs say "may contain tree nuts" while the lids say "contain almonds." The FDA classified the recall as a Class II, which is defined as "a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote." So how do you know if your ice cream is affected? Take a peek at the packaging of your Breyers ice cream tub. Affected products have the lot number: JUL1026GB3 and UPC code: 077567457288. In a statement to PEOPLE, Breyers says: "People with an almond allergy should not consume the product due to risk of serious or life-threatening allergic reaction. The safety and quality of our products is our top priority. For more information, consumers can visit or call 1-800-931-2826." You Might Also Like Can Apple Cider Vinegar Lead to Weight Loss? Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50
